Information Technology Services
Compare Stocks
4 / 10Stock Comparison
AI vs PRCT vs ISRG vs BBAI
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
Medical - Instruments & Supplies
Information Technology Services
AI vs PRCT vs ISRG vs BBAI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Information Technology Services | Medical - Devices | Medical - Instruments & Supplies | Information Technology Services |
| Market Cap | $1.28B | $1.45B | $161.07B | $19.73B |
| Revenue (TTM) | $307M | $322M | $10.58B | $127M |
| Net Income (TTM) | $-435M | $-102M | $2.98B | $-289M |
| Gross Margin | 43.5% | 63.0% | 66.3% | 25.8% |
| Operating Margin | -151.7% | -33.9% | 30.5% | -68.3% |
| Forward P/E | — | — | 43.8x | — |
| Total Debt | $5M | $52M | $303M | $24M |
| Cash & Equiv. | $164M | $287M | $3.37B | $87M |
AI vs PRCT vs ISRG vs BBAI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| C3.ai, Inc. (AI) | 100 | 20.7 | -79.3% |
| PROCEPT BioRobotics… (PRCT) | 100 | 66.7 | -33.3% |
| Intuitive Surgical,… (ISRG) | 100 | 136.8 | +36.8% |
| BigBear.ai Holdings… (BBAI) | 100 | 42.3 | -57.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AI vs PRCT vs ISRG vs BBAI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AI lags the leaders in this set but could rank higher in a more targeted comparison.
PRCT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 37.2%, EPS growth 1.7%, 3Y rev CAGR 60.1%
- 37.2% revenue growth vs BBAI's -19.3%
ISRG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 1.02
- 5.5% 10Y total return vs PRCT's -39.3%
- Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
- Beta 1.02, current ratio 4.87x
BBAI is the clearest fit if your priority is momentum.
- +36.7% vs AI's -57.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 37.2% revenue growth vs BBAI's -19.3% | |
| Quality / Margins | 28.2% margin vs BBAI's -226.7% | |
| Stability / Safety | Beta 1.02 vs BBAI's 3.31, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +36.7% vs AI's -57.0% | |
| Efficiency (ROA) | 14.8% ROA vs AI's -48.5%, ROIC 15.0% vs -35.1% |
AI vs PRCT vs ISRG vs BBAI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AI vs PRCT vs ISRG vs BBAI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ISRG leads in 4 of 6 categories
AI leads 1 • PRCT leads 0 • BBAI leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ISRG is the larger business by revenue, generating $10.6B annually — 83.1x BBAI's $127M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to BBAI's -2.3%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $307M | $322M | $10.6B | $127M |
| EBITDAEarnings before interest/tax | -$455M | -$102M | $3.8B | -$75M |
| Net IncomeAfter-tax profit | -$435M | -$102M | $3.0B | -$289M |
| Free Cash FlowCash after capex | -$127M | -$81M | $2.8B | -$56M |
| Gross MarginGross profit ÷ Revenue | +43.5% | +63.0% | +66.3% | +25.8% |
| Operating MarginEBIT ÷ Revenue | -151.7% | -33.9% | +30.5% | -68.3% |
| Net MarginNet income ÷ Revenue | -141.4% | -31.8% | +28.2% | -2.3% |
| FCF MarginFCF ÷ Revenue | -41.3% | -25.0% | +26.8% | -44.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -46.1% | +20.2% | +23.0% | -0.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -53.2% | -24.4% | +18.8% | +52.0% |
Valuation Metrics
AI leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.3B | $1.4B | $161.1B | $19.7B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $1.2B | $158.0B | $19.7B |
| Trailing P/EPrice ÷ TTM EPS | -4.28x | -14.79x | 57.62x | -5.09x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 43.84x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.65x | — |
| EV / EBITDAEnterprise value multiple | — | — | 43.62x | — |
| Price / SalesMarket cap ÷ Revenue | 3.30x | 4.70x | 16.00x | 154.51x |
| Price / BookPrice ÷ Book value/share | 1.48x | 3.86x | 9.17x | 24.45x |
| Price / FCFMarket cap ÷ FCF | — | — | 64.67x | — |
Profitability & Efficiency
ISRG leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-60 for AI. AI carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRCT's 0.14x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs AI's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -60.4% | -27.7% | +16.9% | -50.7% |
| ROA (TTM)Return on assets | -48.5% | -20.3% | +14.8% | -35.3% |
| ROICReturn on invested capital | -35.1% | -55.7% | +15.0% | -19.5% |
| ROCEReturn on capital employed | -35.5% | -22.5% | +16.5% | -19.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.01x | 0.14x | 0.02x | 0.04x |
| Net DebtTotal debt minus cash | -$160M | -$235M | -$3.1B | -$63M |
| Cash & Equiv.Liquid assets | $164M | $287M | $3.4B | $87M |
| Total DebtShort + long-term debt | $5M | $52M | $303M | $24M |
| Interest CoverageEBIT ÷ Interest expense | — | -30.92x | — | -18.17x |
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $1,701 for AI. Over the past 12 months, BBAI leads with a +36.7% total return vs AI's -57.0%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs AI's -20.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -30.3% | -17.3% | -19.3% | -28.6% |
| 1-Year ReturnPast 12 months | -57.0% | -52.1% | -15.4% | +36.7% |
| 3-Year ReturnCumulative with dividends | -50.2% | -7.8% | +49.6% | +49.5% |
| 5-Year ReturnCumulative with dividends | -83.0% | -39.3% | +58.7% | -56.9% |
| 10-Year ReturnCumulative with dividends | -82.2% | -39.3% | +554.2% | -57.6% |
| CAGR (3Y)Annualised 3-year return | -20.7% | -2.7% | +14.4% | +14.3% |
Risk & Volatility
ISRG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than BBAI's 3.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 75.1% from its 52-week high vs AI's 31.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.53x | 1.23x | 1.02x | 3.31x |
| 52-Week HighHighest price in past year | $30.24 | $66.85 | $603.88 | $9.39 |
| 52-Week LowLowest price in past year | $7.67 | $19.35 | $427.84 | $2.96 |
| % of 52W HighCurrent price vs 52-week peak | +31.7% | +38.1% | +75.1% | +44.4% |
| RSI (14)Momentum oscillator 0–100 | 59.9 | 50.9 | 42.4 | 63.3 |
| Avg Volume (50D)Average daily shares traded | 5.5M | 1.7M | 1.8M | 34.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: AI as "Hold", PRCT as "Buy", ISRG as "Buy", BBAI as "Hold". Consensus price targets imply 74.9% upside for PRCT (target: $45) vs -22.8% for AI (target: $7).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $7.40 | $44.50 | $622.60 | $6.00 |
| # AnalystsCovering analysts | 28 | 15 | 55 | 4 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | 2 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.4% | 0.0% |
ISRG leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AI leads in 1 (Valuation Metrics).
AI vs PRCT vs ISRG vs BBAI: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is AI or PRCT or ISRG or BBAI a better buy right now?
For growth investors, PROCEPT BioRobotics Corporation (PRCT) is the stronger pick with 37.
2% revenue growth year-over-year, versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 6x trailing P/E (43. 8x forward), making it the more compelling value choice. Analysts rate PROCEPT BioRobotics Corporation (PRCT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AI or PRCT or ISRG or BBAI?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +58. 7%, compared to -83. 0% for C3. ai, Inc. (AI). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus AI's -82. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AI or PRCT or ISRG or BBAI?
By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.
(ISRG) is the lower-risk stock at 1. 02β versus BigBear. ai Holdings, Inc. 's 3. 31β — meaning BBAI is approximately 225% more volatile than ISRG relative to the S&P 500. On balance sheet safety, C3. ai, Inc. (AI) carries a lower debt/equity ratio of 1% versus 14% for PROCEPT BioRobotics Corporation — giving it more financial flexibility in a downturn.
04Which is growing faster — AI or PRCT or ISRG or BBAI?
By revenue growth (latest reported year), PROCEPT BioRobotics Corporation (PRCT) is pulling ahead at 37.
2% versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). On earnings-per-share growth, the picture is similar: BigBear. ai Holdings, Inc. grew EPS 35. 4% year-over-year, compared to 1. 7% for PROCEPT BioRobotics Corporation. Over a 3-year CAGR, PRCT leads at 60. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AI or PRCT or ISRG or BBAI?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus -230. 2% for BigBear. ai Holdings, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -83. 4% for AI. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is AI or PRCT or ISRG or BBAI more undervalued right now?
Analyst consensus price targets imply the most upside for PRCT: 74.
9% to $44. 50.
07Which pays a better dividend — AI or PRCT or ISRG or BBAI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is AI or PRCT or ISRG or BBAI better for a retirement portfolio?
For long-horizon retirement investors, Intuitive Surgical, Inc.
(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +554. 2% 10Y return). C3. ai, Inc. (AI) carries a higher beta of 2. 53 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +554. 2%, AI: -82. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between AI and PRCT and ISRG and BBAI?
These companies operate in different sectors (AI (Technology) and PRCT (Healthcare) and ISRG (Healthcare) and BBAI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AI is a small-cap high-growth stock; PRCT is a small-cap high-growth stock; ISRG is a mid-cap high-growth stock; BBAI is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.